Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by bfwon Dec 22, 2017 8:25am
128 Views
Post# 27213070

RE:RE:RE:RE:RE:RE:Why I sold at 6.83 and why I'm happy with it

RE:RE:RE:RE:RE:RE:Why I sold at 6.83 and why I'm happy with it
brianh32 wrote:

For the record - sold at 6.83. TH Stock closed at $6.67 on 2017/12/21. Could buy back in today for $.15 less per share... SELL LOW BUY LOWER. You should attempt to bash when the price that I sell at is lower than the close price. FYI - Took the proceeds and invested into litecoin at 90 usd per coin. Now sitting at $320 per coin - or equivalent of TH jumping from $6.83 to $24.28 Have fun palinc2000 - let me know when TH jumps to $24.28!



Looks like you should have sold your litecoin yesterday.

Down about 30% today.

Do you even understand what you have bought?

bfw
Bullboard Posts